3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
379
Triple Negative Breast Neoplasms
61
Ovarian Neoplasms
46
Prostatic Neoplasms
35
Colorectal Neoplasms
35
Neoplasms
28
Carcinoma, Non-Small-Cell Lung
27
Endometrial Neoplasms
24
Lung Neoplasms
22
Neoplasm Metastasis
21
Uterine Cervical Neoplasms
19
Melanoma
18
Stomach Neoplasms
17
Pancreatic Neoplasms
16
Squamous Cell Carcinoma of Head and Neck
15
Carcinoma, Renal Cell
14
Urinary Bladder Neoplasms
13
Sarcoma
12
Head and Neck Neoplasms
12
Esophageal Neoplasms
11
Colonic Neoplasms
10
Advanced Breast Cancer
9
Small Cell Lung Carcinoma
8
Carcinoma, Transitional Cell
8
Anatomic Stage I Breast Cancer AJCC v8
8
Liver Neoplasms
7
Kidney Neoplasms
7
Cholangiocarcinoma
7
Carcinoma, Hepatocellular
6
Brain Neoplasms
6
Interventions
ribociclib
1
palbociclib
1
abemaciclib
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unilateral Breast Neoplasms
×
Breast
×
30 days
×
Clear all
NCT06760637
2026-05-19
FourLight-3
Pfizer
Phase 3
Active not recruiting
1,035 enrolled
NCT07187726
2026-05-19
PRE-ACT-01
UNICANCER
Phase NA
Recruiting
724 enrolled